These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25647184)

  • 1. Incidence of gammopathies in long-term plasmapheresis donors at Canadian Blood Services.
    Palmer DS; Scalia V; O'Toole J; Welch C; Yi Q; Goldman M
    Transfusion; 2015 Jun; 55(6):1347-54. PubMed ID: 25647184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal gammopathies in a series of 1743 plasma donors.
    Maisnar V; Tichý M; Rehácek V; Palicka V; Malý J
    Acta Medica (Hradec Kralove); 2006; 49(2):119-21. PubMed ID: 16956121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoclonal gammopathies in a series of 1683 plasma donors].
    Tichý M; Rehácek V; Maisnar V; Dominiková K; Palicka V
    Cas Lek Cesk; 2004; 143(6):401-4; discussion 404. PubMed ID: 15309868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Demography and donation frequencies of blood and plasma donor populations in Germany. Update 2010 and 5-year comparison].
    Ritter S; Hamouda O; Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):914-22. PubMed ID: 22842884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective study of monoclonal gammopathies detected in the clinical laboratory of a Spanish healthcare district: 14-year series.
    Bergón E; Miravalles E
    Clin Chem Lab Med; 2007; 45(2):190-6. PubMed ID: 17311507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal gammopathies of undetermined significance. Clinical course and biological aspects of 397 cases].
    Giraldo MP; Rubio-Félix D; Perella M; Gracía JA; Bergua JM; Giralt M
    Sangre (Barc); 1991 Oct; 36(5):377-82. PubMed ID: 1816635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of monoclonal gammopathies in the "well" elderly.
    Crawford J; Eye MK; Cohen HJ
    Am J Med; 1987 Jan; 82(1):39-45. PubMed ID: 3492143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of paraproteinemia in blood donors. Results of systematic analysis of 3800 donors in Trieste].
    Pascali E; Pezzoli A; Zacchi T; Mitri E
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):794-801. PubMed ID: 552827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal gammopathy in a tertiary referral hospital.
    Tamimi W; Alaskar A; Alassiri M; Alsaeed W; Alarifi SA; Alenzi FQ; Jawdat D
    Clin Biochem; 2010 Jun; 43(9):709-13. PubMed ID: 20206156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transient monoclonal gammopathies. Study of 34 cases].
    Giraldo P; Rubio-Félix D; Delgado P; Giralt M
    Sangre (Barc); 1994 Oct; 39(5):351-5. PubMed ID: 7754439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaction rates in allogeneic donors.
    Shehata N; Kusano R; Hannach B; Hume H
    Transfus Med; 2004 Oct; 14(5):327-33. PubMed ID: 15500451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor vigilance data of a blood transfusion service: A multicenter analysis.
    Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
    Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related donor return patterns among first-time blood donors in the United States.
    Notari EP; Zou S; Fang CT; Eder AF; Benjamin RJ; Dodd RY
    Transfusion; 2009 Oct; 49(10):2229-36. PubMed ID: 19903284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal gammopathies: classification of laboratory tests].
    D'Angelo G; Giardini C; Calvano D; Braghini T
    Minerva Med; 1985 Oct; 76(41):1921-6. PubMed ID: 3932901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IgG and IgM levels in new and regular long-term plasmapheresis donors.
    Burgin M; Hopkins G; Moore B; Nasser J; Richardson A; Minchinton R
    Med Lab Sci; 1992 Dec; 49(4):265-70. PubMed ID: 1339930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and identification of monoclonal gammopathies by capillary electrophoresis.
    Henskens Y; de Winter J; Pekelharing M; Ponjee G
    Clin Chem; 1998 Jun; 44(6 Pt 1):1184-90. PubMed ID: 9625041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory screening of monoclonal gammopathies: incidence of serum monoclonal immunoglobulins during a five years survey in a general hospital.
    Sala P; Tonutti E; Giuliano M; Fuccaro V; Bramezza M
    Boll Ist Sieroter Milan; 1989; 68(3):224-7. PubMed ID: 2491429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.